Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis

Basic Research in Cardiology

Volumn 108, Issue 5, 2013, Pages

  Davidson, Sean M ^a   Selvaraj, Pradeep ^a   He, David ^a   Boi Doku, Claire ^a   Yellon, Robert L ^a   Vicencio, Jose M ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AMD3100; Ischaemia; Remote preconditioning; Reperfusion; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIPEPTIDASE; DIPEPTIDASE IV; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION; HEART PAPILLARY MUSCLE; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; REMOTE ISCHEMIC CONDITIONING; SIGNAL TRANSDUCTION;

EID: 84880962670     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0377-6     Document Type: Article

References (47)

1. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305. doi: 10.1161/01.CIR.0000147780.30124.CF (Pubitemid 39557491)
2. Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P (2013) Remote ischemic preconditioning regulates HIF-1alpha levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol 108:314. doi: 10.1007/s00395-012-0314-0
3. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727-734. doi: 10.1016/S0140-6736(09)62001-8
4. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK (2011) Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 106:135-145. doi: 10.1007/s00395-010-0133-0
5. Cai ZP, Parajuli N, Zheng X, Becker L (2012) Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 107:277. doi: 10.1007/s00395-012-0277-1
6. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864. doi: 10.1038/nm1075 (Pubitemid 39070860)
7. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D (2008) Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571-579. doi: 10.1038/sj.mt.6300374 (Pubitemid 351314998)
8. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN (2006) Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47:2277-2282. doi: 10.1016/j.jacc.2006.01.066 (Pubitemid 43795071)
9. Davidson SM, Hausenloy D, Duchen MR, Yellon DM (2006) Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38:414-419. doi: 10.1016/j.biocel.2005.09.017 (Pubitemid 41821888)
10. De Clercq E (2003) The bicyclam AMD3100 story. Nat Rev Drug Discov 2:581-587. doi: 10.1038/nrd1134 (Pubitemid 37361749)
11. Dickson EW, Porcaro WA, Fenton RA, Heard SO, Reindhardt CP, Renzi FP, Przyklenk K (2000) "Preconditioning at a distance" in the isolated rabbit heart. Acad Emerg Med 7:311-317. doi: 10.1111/j.1553-2712.2000.tb02228.x (Pubitemid 30207969)
12. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M (2011) SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 129:97-108. doi: 10.1016/j.pharmthera.2010.09.011
13. Hatse S, Princen K, Bridger G, De Clercq E, Schols D (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527:255-262. doi: 10.1016/S0014-5793(02)03143-5 (Pubitemid 35253875)
14. Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14:893-907. doi: 10.1089/ars.2010.3360
15. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di SC, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370:575-579. doi: 10.1016/S0140-6736(07)61296-3 (Pubitemid 47247853)
16. Hausenloy DJ, Yellon DM (2008) Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79:377-386. doi: 10.1093/cvr/cvn114
17. Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8:619-629. doi: 10.1038/nrcardio.2011. 85
18. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166-175. doi: 10.1016/S0140-6736(12)60916- 7
19. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 110:111-115. doi: 10.1161/CIRCRESAHA.111. 259556
20. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP (2009) Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 119:820-827. doi: 10.1161/CIRCULATIONAHA. 108.809723
21. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116:654-663. doi: 10.1161/circulationaha.106. 672451 (Pubitemid 47356350)
22. Huang C, Gu H, Zhang W, Manukyan MC, Shou W, Wang M (2011) SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 301:H1496-H1505. doi: 10.1152/ajpheart.00365.2011
23. Jensen RV, Stottrup NB, Kristiansen SB, Botker HE (2012) Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 107:285. doi: 10.1007/s00395-012-0285-1
24. Jiang Q, Song P, Wang E, Li J, Hu S, Zhang H (2013) Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J Mol Cell Cardiol 56:1-7. doi: 10.1016/j.yjmcc.2012.12.016
25. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75:1240-1247. doi: 10.1124/mol.108.053389
26. Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Kubo M, Kobayashi T, Mikamo A, Ikeda Y, Matsuzaki M, Hamano K (2009) Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 53:1814-1822. doi: 10.1016/j.jacc.2009.02.015
27. Kanki S, Segers VF, Wu W, Kakkar R, Gannon J, Sys SU, Sandrasagra A, Lee RT (2011) Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 4:509-518. doi: 10.1161/CIRCHEARTFAILURE. 110.960302
28. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106:2881-2883. doi: 10.1161/01.CIR.0000043806.51912.9B (Pubitemid 35424735)
29. Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E (2013) Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther 29(27):359-361. doi: 10.1007/s10557-013-6451-3
30. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J (2012) Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand 56:30-38. doi: 10.1111/j.1399-6576.2011.02585.x
31. Misra P, Lebeche D, Ly H, Schwarzkopf M, Diaz G, Hajjar RJ, Schecter AD, Frangioni JV (2008) Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med 49:963-969. doi: 10.2967/jnumed.107. 050054 (Pubitemid 351793437)
32. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87:406-423. doi: 10.1093/cvr/cvq129
33. Sandhu R, Diaz RJ, Wilson GJ (1993) Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovasc Res 27:602-607 (Pubitemid 23144583)
34. Sasaki T, Fukazawa R, Ogawa S, Kanno S, Nitta T, Ochi M, Shimizu K (2007) Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49:966-971. doi: 10.1111/j.1442-200X.2007. 02491.x (Pubitemid 350197152)
35. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117:2224-2231. doi: 10.1161/circulationaha. 107.694992
36. Segret A, Rucker-Martin C, Pavoine C, Flavigny J, Deroubaix E, Chatel MA, Lombet A, Renaud JF (2007) Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J Histochem Cytochem 55:141-150. doi: 10.1369/jhc.6A7050.2006 (Pubitemid 46147691)
37. Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH (2007) Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 49:214-220. doi: 10.1097/FJC.0b013e3180325ad9 (Pubitemid 46626013)
38. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci 117:191-200. doi: 10.1042/CS20080523
39. Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ, Yellon DM (2011) Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 16:63-71. doi: 10.1177/1074248410382232
40. Takahashi M (2010) Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 74:418-423. doi: 10.1253/circj.CJ-09-1021
41. Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D, Furber A, Prunier F (2011) RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 106:1329-1339. doi: 10.1007/s00395-011-0210- z
42. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209-1216. doi: 10.1161/CIRCRESAHA.109.197723
43. Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J, Jakob H, Heusch G (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105:657-664. doi: 10.1007/s00395-010- 0104-5
44. Wong D, Korz W (2008) Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 14:7975-7980. doi: 10.1158/1078-0432.CCR-07-4846
45. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121-1135. doi: 10.1056/NEJMra071667 (Pubitemid 47443217)
46. Zaruba MM, Franz WM (2010) Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther 10:321-335. doi: 10.1517/14712590903460286
47. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, Fischer R, Krieg L, Hirsch E, Huber B, Nathan P, Israel L, Imhof A, Herbach N, Assmann G, Wanke R, Mueller-Hoecker J, Steinbeck G, Franz WM (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4:313-323. doi: 10.1016/j.stem.2009.02.013